Yang Xisheng, Wang Jianlin, Qu Shibin, Zhang Hongtao, Ruan Bai, Gao Yuan, Ma Ben, Wang Xing, Wu Nan, Li Xiaolei, Dou Kefeng, Li Haimin
Department of Hepatobiliary Surgery, The Xijing Hospital of The Fourth Military Medical Uiversity, Xi'an, China.
Oncotarget. 2015 Apr 10;6(10):7918-29. doi: 10.18632/oncotarget.3486.
Although microRNA-200a (miR-200a) is frequently downregulated in cancer, its role in side population (SP) has not been investigated. In this study, 101 pairs of primary hepatocellular carcinoma (HCC) tissues and matched normal control tissues were analyzed for miR-200a expression and its clinicopathological value was determined. We found that miR-200a was downregulated in HCC/SP and this was associated metastasis. MiR-200a suppressed metastasis of SP cells. Overexpression of miR-200a in SP cells decreased metastasis-related markers and expression of ZEB2. The associations between miR-200a, SP cells and ZEB2 were validated in HCC. These findings reveal that miR-200a suppresses metastasis of SP cells by downregulating ZEB2.
尽管微小RNA-200a(miR-200a)在癌症中经常下调,但其在侧群细胞(SP)中的作用尚未得到研究。在本研究中,分析了101对原发性肝细胞癌(HCC)组织及其匹配的正常对照组织中的miR-200a表达,并确定了其临床病理价值。我们发现miR-200a在HCC/SP中下调,且这与转移相关。miR-200a抑制SP细胞的转移。SP细胞中miR-200a的过表达降低了转移相关标志物和ZEB2的表达。miR-200a、SP细胞和ZEB2之间的关联在HCC中得到了验证。这些发现揭示了miR-200a通过下调ZEB2抑制SP细胞的转移。